Turning Point Therapeutics Names Andrew Partridge As Executive Vice President and Chief Commercial Officer

    NEXT STORY
    Global Environmental Testing Industry
    PREV STORY
    Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to Develop QR-313 for the Treatment of Dystrophic Epidermolysis Bullosa

    The funding will be used for the clinical development of QR-313 Clinical trial in ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Notes into shares

    FIT Biotech Oy Company release October 14, 2016 at 09.30 am EETConversion of FIT ...

    author_avatar
    NASDAQ Market News

    Horizon Pharma plc Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments

    -- Increases KRYSTEXXA®(pegloticase injection) Estimated Peak Annual Net Sales to more than $750 Million ...

    author_avatar
    NASDAQ Market News